166 related articles for article (PubMed ID: 23742090)
21. Glycation and post-translational processing of human interferon-gamma expressed in Escherichia coli.
Mironova R; Niwa T; Dimitrova R; Boyanova M; Ivanov I
J Biol Chem; 2003 Dec; 278(51):51068-74. PubMed ID: 14525998
[TBL] [Abstract][Full Text] [Related]
22. Long-term stabilization of recombinant human interferon alpha 2b in aqueous solution without serum albumin.
Ruiz L; Reyes N; Duany L; Franco A; Aroche K; Hardy Rando E
Int J Pharm; 2003 Oct; 264(1-2):57-72. PubMed ID: 12972336
[TBL] [Abstract][Full Text] [Related]
23. Improving purification of recombinant human interferon gamma expressed in Escherichia coli; effect of removal of impurity on the process yield.
Mohammadian-Mosaabadi J; Naderi-Manesh H; Maghsoudi N; Nassiri-Khalili MA; Masoumian MR; Malek-Sabet N
Protein Expr Purif; 2007 Feb; 51(2):147-56. PubMed ID: 16908190
[TBL] [Abstract][Full Text] [Related]
24. Refolding and purification of interferon-gamma in industry by hydrophobic interaction chromatography.
Geng X; Bai Q; Zhang Y; Li X; Wu D
J Biotechnol; 2004 Sep; 113(1-3):137-49. PubMed ID: 15380653
[TBL] [Abstract][Full Text] [Related]
25. Betaseron.
Lin L
Dev Biol Stand; 1998; 96():97-104. PubMed ID: 9890522
[TBL] [Abstract][Full Text] [Related]
26. [Effect of mobile phase on the mass recovery of rhIFN-gamma in protein folding liquid chromatography].
Wu D; Wang C; Geng X
Se Pu; 2007 Mar; 25(2):197-202. PubMed ID: 17580685
[TBL] [Abstract][Full Text] [Related]
27. Purification of recombinant human interferon-epsilon and oligonucleotide microarray analysis of interferon-epsilon-regulated genes.
Peng FW; Duan ZJ; Zheng LS; Xie ZP; Gao HC; Zhang H; Li WP; Hou YD
Protein Expr Purif; 2007 Jun; 53(2):356-62. PubMed ID: 17287131
[TBL] [Abstract][Full Text] [Related]
28. Some factors affecting the stability of interferon alpha 2b in solution.
Ruiz L; Reyes N; Aroche K; Báez R; Aldana R; Hardy E
Biologicals; 2006 Mar; 34(1):15-9. PubMed ID: 16188456
[TBL] [Abstract][Full Text] [Related]
29. Protein folding liquid chromatography.
Bai Q; Geng X
Methods Mol Biol; 2011; 705():69-85. PubMed ID: 21125381
[TBL] [Abstract][Full Text] [Related]
30. Structural analysis of modified forms of recombinant IFN-beta produced under stress-simulating conditions.
Orrù S; Amoresano A; Siciliano R; Napoleoni R; Finocchiaro O; Datola A; De Luca E; Sirna A; Pucci P
Biol Chem; 2000 Jan; 381(1):7-17. PubMed ID: 10722045
[TBL] [Abstract][Full Text] [Related]
31. [Purification and identification of human recombinant IFN-beta expressed in yeast Pichia pastoris].
Yu QW; Li NL; Nie H; Ma AL; Xi B; Gong Y; Zhang DQ
Sheng Wu Hua Xue Yu Sheng Wu Wu Li Xue Bao (Shanghai); 2003 Nov; 35(11):1035-9. PubMed ID: 14614543
[TBL] [Abstract][Full Text] [Related]
32. Characterization of human interferon-gamma and human interleukin-2 from recombinant mammalian cell lines and peripheral blood lymphocytes.
Riske FJ; Cullen BR; Chizzonite R
Lymphokine Cytokine Res; 1991 Jun; 10(3):213-8. PubMed ID: 1909189
[TBL] [Abstract][Full Text] [Related]
33. Molecular and Biological Characterization of a Prepared Recombinant Human Interferon Alpha 2b Isoform.
Shaaban R; El-Sayed WM; Samir S; El-Dabaa E
Appl Biochem Biotechnol; 2019 May; 188(1):72-86. PubMed ID: 30334171
[TBL] [Abstract][Full Text] [Related]
34. An Albumin-Free Formulation for Escherichia coli-Derived Interferon Beta-1b with Decreased Immunogenicity in Immune Tolerant Mice.
Abdolvahab MH; Fazeli A; Radmalekshahi M; Nejadnik MR; Fazeli MR; Schellekens H
J Interferon Cytokine Res; 2016 Mar; 36(3):192-203. PubMed ID: 26824268
[TBL] [Abstract][Full Text] [Related]
35. Specific binding of interferon-gamma to high affinity receptors on human erythroid colony-forming cells.
Taniguchi S; Dai CH; Krantz SB
Exp Hematol; 1997 Mar; 25(3):193-8. PubMed ID: 9091293
[TBL] [Abstract][Full Text] [Related]
36. Bacterial fermentation of recombinant major wasp allergen Antigen 5 using oxygen limiting growth conditions improves yield and quality of inclusion bodies.
Kischnick S; Weber B; Verdino P; Keller W; Sanders EA; Anspach FB; Fiebig H; Cromwell O; Suck R
Protein Expr Purif; 2006 Jun; 47(2):621-8. PubMed ID: 16495080
[TBL] [Abstract][Full Text] [Related]
37. On-column refolding of recombinant human interferon-gamma inclusion bodies by expanded bed adsorption chromatography.
Jin T; Guan YX; Yao SJ; Lin DQ; Cho MG
Biotechnol Bioeng; 2006 Mar; 93(4):755-60. PubMed ID: 16261630
[TBL] [Abstract][Full Text] [Related]
38. Cloning and optimization of induction conditions for mature PsaA (pneumococcal surface adhesin A) expression in Escherichia coli and recombinant protein stability during long-term storage.
Larentis AL; Argondizzo AP; Esteves Gdos S; Jessouron E; Galler R; Medeiros MA
Protein Expr Purif; 2011 Jul; 78(1):38-47. PubMed ID: 21362478
[TBL] [Abstract][Full Text] [Related]
39. Expression of recombinant human interferon-γ with antiviral activity in the bi-cistronic baculovirus-insect/larval system.
Chen WS; Villaflores OB; Jinn TR; Chan MT; Chang YC; Wu TY
Biosci Biotechnol Biochem; 2011; 75(7):1342-8. PubMed ID: 21737931
[TBL] [Abstract][Full Text] [Related]
40. [Expression and antiviral assay of bovine interferon-gamma].
'u Z; Chen X; Shan F; Meng C; Sun L; Huang J; Pan Z; Geng S; Jiao X
Sheng Wu Gong Cheng Xue Bao; 2011 Feb; 27(2):269-76. PubMed ID: 21650053
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
